CLAIM CARD
The cardiometabolic evidence base comprises ten studies spanning observational cohorts, randomized controlled trials, systematic reviews, and preclinical models, with the majority focusing on adults with type 2 diabetes mellitus. Baniasadi 2025 and Bahari 2025 each conducted GRADE-assessed systematic reviews and dose-response meta-analyses of randomized controlled trials in prediabetic and diabetic populations, providing pooled estimates across multiple intervention studies.
Evidence grade: exploratory
Contradiction status: none
Publication: 2ed54f5a-fbc9-45ec-8fa9-5be79af12b17
Provenance: Derivation Web chain
Citation Support
source_1Flensted-Jensen 2025source_2Flensted-Jensen 2025bsource_3Xu 2025source_4El-Rakabawy 2025source_5Schonenberger 2025